Dokkyo Medical University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02301806
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Dokkyo Medical University, Koshigaya Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

glimepiride (amaryl) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2